PL2254570T3 - Połączenie zawierające paklitaksel do leczenia raka jajnika - Google Patents

Połączenie zawierające paklitaksel do leczenia raka jajnika

Info

Publication number: PL2254570T3
Authority: PL; Poland
Prior art keywords: paclitaxel; combination; ovarian cancer; treating ovarian; treating
Prior art date: 2008-02-20

Application number

PL09712334T

Other languages

English (en)

Inventor

Martine Clozel

Urs Regenass

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-02-20

Filing date

2009-02-19

Publication date

2014-05-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40670930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2254570(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-02-19 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2014-05-30 Publication of PL2254570T3 publication Critical patent/PL2254570T3/pl

Links

206010033128 Ovarian cancer Diseases 0.000 title 1
206010061535 Ovarian neoplasm Diseases 0.000 title 1
229930012538 Paclitaxel Natural products 0.000 title 1
229960001592 paclitaxel Drugs 0.000 title 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL09712334T 2008-02-20 2009-02-19 Połączenie zawierające paklitaksel do leczenia raka jajnika PL2254570T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IB2008050607		2008-02-20
PCT/IB2009/050677 WO2009104149A1 (en)	2008-02-20	2009-02-19	Combination comprising paclitaxel for treating ovarian cancer
EP09712334.3A EP2254570B1 (en)	2008-02-20	2009-02-19	Combination comprising paclitaxel for treating ovarian cancer

Publications (1)

Publication Number	Publication Date
PL2254570T3 true PL2254570T3 (pl)	2014-05-30

Family

ID=40670930

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09712334T PL2254570T3 (pl)	2008-02-20	2009-02-19	Połączenie zawierające paklitaksel do leczenia raka jajnika

Country Status (19)

Country	Link
US (2)	US8541433B2 (pl)
EP (1)	EP2254570B1 (pl)
JP (1)	JP5514123B2 (pl)
KR (1)	KR20100132489A (pl)
CN (1)	CN101939001B (pl)
AR (1)	AR070456A1 (pl)
AU (1)	AU2009215329B2 (pl)
CA (1)	CA2714608A1 (pl)
CY (1)	CY1115071T1 (pl)
DK (1)	DK2254570T3 (pl)
ES (1)	ES2446303T3 (pl)
HR (1)	HRP20140215T1 (pl)
MX (1)	MX2010008994A (pl)
PL (1)	PL2254570T3 (pl)
PT (1)	PT2254570E (pl)
RU (1)	RU2494736C2 (pl)
SI (1)	SI2254570T1 (pl)
TW (1)	TWI441639B (pl)
WO (1)	WO2009104149A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007031933A2 (en)	2005-09-12	2007-03-22	Actelion Pharmaceuticals Ltd	Stable pharmaceutical composition comprising a pyrimidine-sulfamide
MX2010001837A (es)	2007-08-17	2010-03-10	Actelion Pharmaceuticals Ltd	Derivados de 4-pirimidinasulfamida.
PL2254570T3 (pl) *	2008-02-20	2014-05-30	Actelion Pharmaceuticals Ltd	Połączenie zawierające paklitaksel do leczenia raka jajnika
JP5764061B2 (ja)	2008-08-13	2015-08-12	アクテリオンファーマシューティカルズリミテッドＡｃｔｅｌｉｏｎＰｈａｒｍａｃｅｕｔｉｃａｌｓＬｔｄ	マシテンタン含有治療用組成物
PT2464218E (pt)	2009-08-10	2015-09-16	Univ Texas	Tratamento de metástases do cérebro com inibidores de recetores de endotelina, em combinação com um agente quimioterapêutico citotóxico
AU2012213036A1 (en)	2011-02-04	2013-09-19	Actelion Pharmaceuticals Ltd	Combinations comprising macitentan for the treatment of glioblastoma multiforme
CN103819411A (zh) *	2014-03-14	2014-05-28	成都克莱蒙医药科技有限公司	一种马西替坦中间体新的制备方法
SG11201608303QA (en)	2014-04-04	2016-11-29	Del Mar Pharmaceuticals	Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW406020B (en) *	1993-09-29	2000-09-21	Bristol Myers Squibb Co	Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
AU2002227984B8 (en) *	2000-12-18	2007-01-04	Actelion Pharmaceuticals Ltd.	Novel sulfamides and their use as endothelin receptor antagonists
CA2502848C (en)	2002-10-24	2012-10-02	The Board Of Trustees Of The University Of Illinois	Use of irl-1620 and paclitaxel for preventing and treating breast tumors
US20040121971A1 (en) *	2002-12-20	2004-06-24	Gang Chen	Therapeutic use of tumor necrosis factor-alpha mutein
GB0425854D0 (en)	2004-11-25	2004-12-29	Astrazeneca Ab	Therapeutic treatment
WO2007031933A2 (en)	2005-09-12	2007-03-22	Actelion Pharmaceuticals Ltd	Stable pharmaceutical composition comprising a pyrimidine-sulfamide
AR062501A1 (es)	2006-08-29	2008-11-12	Actelion Pharmaceuticals Ltd	Composiciones terapeuticas
PL2254570T3 (pl) *	2008-02-20	2014-05-30	Actelion Pharmaceuticals Ltd	Połączenie zawierające paklitaksel do leczenia raka jajnika
KR20100005486A (ko) *	2008-07-07	2010-01-15	페어차일드코리아반도체 주식회사	스위치 제어 장치 및 이를 포함하는 컨버터

2009
- 2009-02-19 PL PL09712334T patent/PL2254570T3/pl unknown
- 2009-02-19 SI SI200930849T patent/SI2254570T1/sl unknown
- 2009-02-19 HR HRP20140215AT patent/HRP20140215T1/hr unknown
- 2009-02-19 EP EP09712334.3A patent/EP2254570B1/en not_active Not-in-force
- 2009-02-19 MX MX2010008994A patent/MX2010008994A/es active IP Right Grant
- 2009-02-19 PT PT97123343T patent/PT2254570E/pt unknown
- 2009-02-19 DK DK09712334.3T patent/DK2254570T3/da active
- 2009-02-19 JP JP2010547291A patent/JP5514123B2/ja not_active Expired - Fee Related
- 2009-02-19 CA CA2714608A patent/CA2714608A1/en not_active Abandoned
- 2009-02-19 WO PCT/IB2009/050677 patent/WO2009104149A1/en not_active Ceased
- 2009-02-19 RU RU2010138650/15A patent/RU2494736C2/ru not_active IP Right Cessation
- 2009-02-19 ES ES09712334.3T patent/ES2446303T3/es active Active
- 2009-02-19 US US12/867,939 patent/US8541433B2/en not_active Expired - Fee Related
- 2009-02-19 KR KR1020107018516A patent/KR20100132489A/ko not_active Abandoned
- 2009-02-19 TW TW098105324A patent/TWI441639B/zh not_active IP Right Cessation
- 2009-02-19 CN CN2009801042583A patent/CN101939001B/zh not_active Expired - Fee Related
- 2009-02-19 AU AU2009215329A patent/AU2009215329B2/en not_active Ceased
- 2009-02-20 AR ARP090100596A patent/AR070456A1/es unknown
2013
- 2013-08-01 US US13/957,126 patent/US20130317048A1/en not_active Abandoned
2014
- 2014-02-26 CY CY20141100152T patent/CY1115071T1/el unknown

Also Published As

Publication number	Publication date
MX2010008994A (es)	2010-09-07
ES2446303T3 (es)	2014-03-07
CY1115071T1 (el)	2016-12-14
EP2254570B1 (en)	2013-12-18
US8541433B2 (en)	2013-09-24
PT2254570E (pt)	2014-02-17
DK2254570T3 (da)	2014-02-03
CN101939001A (zh)	2011-01-05
RU2494736C2 (ru)	2013-10-10
TW200940062A (en)	2009-10-01
RU2010138650A (ru)	2012-03-27
JP2011512399A (ja)	2011-04-21
KR20100132489A (ko)	2010-12-17
AU2009215329A1 (en)	2009-08-27
SI2254570T1 (sl)	2014-03-31
CA2714608A1 (en)	2009-08-27
CN101939001B (zh)	2012-06-20
AR070456A1 (es)	2010-04-07
EP2254570A1 (en)	2010-12-01
HRP20140215T1 (hr)	2014-04-11
TWI441639B (zh)	2014-06-21
US20130317048A1 (en)	2013-11-28
US20100311774A1 (en)	2010-12-09
AU2009215329B2 (en)	2014-08-21
JP5514123B2 (ja)	2014-06-04
WO2009104149A1 (en)	2009-08-27

Publication	Publication Date	Title
HUE045548T2 (hu)	2019-12-30	Rák kezelésére hasznos gyógyszer
IL209895A0 (en)	2011-02-28	Compounds for treating beta-amyloidoses
IL213398A0 (en)	2011-07-31	Compounds for treating cancer
PL2061561T3 (pl)	2013-12-31	Kompozycje do leczenia raka
PT2303021T (pt)	2019-04-01	Compostos para tratamento do cancro
EP2424516A4 (en)	2014-04-02	PENTAMIDINE COMBINATIONS FOR THE TREATMENT OF CANCER
ZA201003123B (en)	2011-04-28	Thiazol derivavtives for treating cancer
ZA201203449B (en)	2013-01-31	Sulfoxide derivatives for treating tumors
PL2254570T3 (pl)	2014-05-30	Połączenie zawierające paklitaksel do leczenia raka jajnika
GB0804496D0 (en)	2008-04-16	Treating cancer
EP2144888A4 (en)	2012-10-03	METHODS OF TREATING CANCER
ZA201103061B (en)	2012-04-25	Stabilized composition for treating psoriasis
LT2467140T (lt)	2016-09-12	Lapatinibas, skirtas vėžio gydymui
BRPI0918508A2 (pt)	2015-12-08	orto-aminoanilidas para o tratamento de câncer
GB0707556D0 (en)	2007-05-30	Treatment for cancer
EP2307573A4 (en)	2011-11-16	METHODS FOR SCREENING COMPOUNDS FOR TREATING CANCER
GB0809046D0 (en)	2008-06-25	Cancer treatment
EP2319873A4 (en)	2011-06-22	DEXTRAN TO TREAT LUNG CANCER
GB0914322D0 (en)	2009-09-30	Compounds for treating cancer
GB0808116D0 (en)	2008-06-11	bioarker for pancreatic cancer
GB0619271D0 (en)	2006-11-08	Treating cancer
GB0722030D0 (en)	2007-12-19	Compositions for treating tumours
GB0814469D0 (en)	2008-09-10	Treatment for tumours
GB0908537D0 (en)	2009-06-24	Compositions for treating tumours
GB0723503D0 (en)	2008-01-09	Cancer treatment